3 Ways To Prevent Supply Chain Risk In The Pharmaceutical Industry

1
3 Ways To Prevent Supply Chain Risk In The
Pharmaceutical Industry
2

• About Pinnacle Lifescience

• Pinnacle Life Science is a 100 subsidiary of
  Indias most trusted pharmaceutical company Aarti
  Drugs Ltd (ADL) and forms part of 1.5 billion
  conglomerate of the esteemed Aarti Group of
  Industries.
• With 35 years of healthcare commitment through
  Aarti Drugs, Pinnacle has made its presence in
  nearly 90 countries. Treading carefully on the
  path of efficient healthcare, the
  state-of-the-art manufacturing facility is
  designed to produce formulations that meet
  international quality standards and stringent
  regulatory compliances to trade beyond borders.
• With significant expansion in RD, Manufacturing
  Marketing capabilities, we are poised for an
  accelerated growth.

3

• 3 Ways To Prevent Supply Chain Risk In The
  Pharmaceutical Industry Pinnacle Life Science

• Did you know the global value of pharmaceutical
  items traded has increased sixfold in the last
  two decades? From 113 billion in 2000 to 629
  billion in 2019, supply chains have become
  increasingly global, complicated, and opaque due
  to this expansion.
• Companies are exponentially using contract
  manufacturers for production, introducing new
  modalities, and experimenting with fresh ways to
  contact patients. Pharmaceutical supply chains
  could suffer significant losses if they do not
  examine and plan for these developments risks.
• Supply-chain risk is a significant factor for
  pharma companies susceptibility to disruption.
  Knowledge of the nature of the supply chains
  risks is the first step in establishing
  supply-chain resilience.

4

• End-To-End Transparency

• A lack of visibility into suppliers business
  activities can be a substantial risk for pharma
  businesses. For instance, exploitation of child
  labour by suppliers overseas can make brands
  inadvertently participate in unethical labour
  practices.
• To have an end-to-end perspective of the supply
  chain and detect weaknesses, a corporation must
  map its suppliers by tier. Its critical to
  understand exposures beyond supply, such as how
  items are manufactured, delivered, and kept. Each
  stage has its own set of issues. A minor
  transportation providers insolvency is a vital
  area for example, it might bring an entire
  supply chain to a halt.

5

• End-To-End Transparency

• It is vital to gather leading and lagging
  resilience metrics in seven areas from internal
  and external data sources to get a comprehensive
  picture of each stages ongoings
• Data Security
• Finance
• Operations
• Organisational Maturity
• Regulation
• Reputation
• Structure

6

• Routine Stress Testing And Re-Evaluation

• Companies frequently employ scenario planning and
  simulation models to predict their
  vulnerabilities, evaluate the potential impact,
  and minimise the consequences.
• During the COVID-19 pandemic, for example, a
  leading pharmaceutical business employed a
  digital-twin simulation to comprehend better the
  impact of production slowdowns and shutdowns on
  patient drug supplies. This allowed the
  corporation to recognise that it had more time
  than expected to create and implement safer
  working practices in its production plants.
• Therefore, the best solutions were possible. Once
  a corporation has visibility into its supply
  chain, it can continuously assess the possibility
  of various hazards.

7

• Measures To Reduce Shock Exposure

• Expanding the network of suppliers is one of the
  most prevalent ways for robustness. Depending on
  a single source for vital components or raw
  materials or several suppliers located in the
  exact location can be a weakness.
• However, multi-sourcing isnt the sole solution.
  A corporation can take measures to balance
  inventory levels better. It can fortify physical
  assets to withstand hurricanes and storm surges
  and provide financial support to troubled but
  critical suppliers.
• More information https//www.pinnaclelifescience
  .com/2022/01/10/3-ways-to-prevent-supply-chain-ris
  k-in-the-pharmaceutical-industry/

8
Contact Us
Address Mahendra Industrial Estate, Ground
Floor, Plot No. 109D, Road No 29, Sion(E)
Mumbai-400022, India. Phone No  91 (22)
24019025 Email export.pinnacle_at_aartidrugs.com Sit
e www.pinnaclelifescience.com
9
(No Transcript)